These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 15339679)

  • 21. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
    Peh SC; Kim LH; Poppema S
    Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].
    Hartmann S; Cogliatti S; Hansmann ML
    Pathologe; 2013 May; 34(3):233-43. PubMed ID: 23494280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.
    Chittal SM; Brousset P; Voigt JJ; Delsol G
    Histopathology; 1991 Sep; 19(3):211-20. PubMed ID: 1655614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
    van den Berg A; Visser L; Poppema S
    Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-cell rich B-cell lymphoma--a case report.
    Pai RR; Khadilkar UN; Pai MR; Dinesh M
    Indian J Pathol Microbiol; 2003 Jul; 46(3):427-8. PubMed ID: 15025291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone marrow involvement in T-cell-rich B-cell lymphoma.
    Skinnider BF; Connors JM; Gascoyne RD
    Am J Clin Pathol; 1997 Nov; 108(5):570-8. PubMed ID: 9353097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
    Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
    Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis and differential diagnosis of nodular lymphocyte-predominant Hodgkin's lymphoma.
    Liu Y; Zhu X; Zhuang H; Lin H; Wu Q; Jiang G; Gu Y; Luo D; Luo X
    Zhonghua Bing Li Xue Za Zhi; 2002 Jun; 31(3):227-30. PubMed ID: 12475440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Update on nodular lymphocyte predominant Hodgkin's lymphoma and related lesions].
    Hartmann S; Hansmann ML
    Pathologe; 2017 Feb; 38(1):3-10. PubMed ID: 27999937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clusterin expression in malignant lymphomas: a survey of 266 cases.
    Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
    Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [T-cell-rich B-cell lymphoma: multifactorial study of 4 cases].
    Moreno MM; Fernández-Flores A; Paradela A; Rodríguez JM; Ageitos A; Gonzalo I; Marcos B; Robledo M; Rivas C
    Sangre (Barc); 1995 Dec; 40(6):471-7. PubMed ID: 8850230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
    Hansmann ML; Küppers R
    Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of combining antigranulocyte with antileukocyte antibodies in differentiating Hodgkin's disease from non-Hodgkin's lymphoma.
    Medeiros LJ; Weiss LM; Warnke RA; Dorfman RF
    Cancer; 1988 Dec; 62(12):2475-81. PubMed ID: 2973368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocyte predominance Hodgkin's disease: the use of bcl-6 and CD57 in diagnosis and differential diagnosis.
    Kraus MD; Haley J
    Am J Surg Pathol; 2000 Aug; 24(8):1068-78. PubMed ID: 10935647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
    Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
    Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. J chain and myocyte enhancer factor 2B are useful in differentiating classical Hodgkin lymphoma from nodular lymphocyte predominant Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
    Moore EM; Swerdlow SH; Gibson SE
    Hum Pathol; 2017 Oct; 68():47-53. PubMed ID: 28851661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Feline Hodgkin's-like lymphoma: 20 cases (1992-1999).
    Walton RM; Hendrick MJ
    Vet Pathol; 2001 Sep; 38(5):504-11. PubMed ID: 11572557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The distinction of Hodgkin's disease from T cell lymphoma.
    Banks PM
    Semin Diagn Pathol; 1992 Nov; 9(4):279-83. PubMed ID: 1480849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.